Trials / Unknown
UnknownNCT03305224
The Combination Therapy With Ra-223 and Enzalutamide
The Study of Combination Therapy With Radium-223 and Enzalutamide in Osaka City University
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Taro Iguchi, MD, PHD · Academic / Other
- Sex
- Male
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate preliminary efficacy of Ra-223 in combination with Enzalutamide in progressive CRPC patients with bone metastasis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ra-223 in combination with enzalutamide | Ra-223 (55 kBq/kg i.v.) 6 injections at 4 weeks interval in combination with enzalutamide 160 mg per a day |
Timeline
- Start date
- 2017-10-27
- Primary completion
- 2021-10-30
- Completion
- 2022-03-31
- First posted
- 2017-10-09
- Last updated
- 2021-09-09
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03305224. Inclusion in this directory is not an endorsement.